Download FREE Sample
Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Vaccine CDMO Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive In"4">
- Market Overview
- Market Dynamics
- Drivers
- Increasing demand for vaccines
- Rising biopharma and government partnerships with CDMOs
- Advancements in vaccine manufacturing technologies
- Growing need for specialized CDMO services for new vaccine technologies
- Increasing private and public investments in vaccine CDMOs
- Increasing outsourcing trend to reduce costs and accelerate time-to-market
- Restraints
- High initial capital investment
- Complex regulatory environment
- Supply chain and raw material shortages
- Opportunities
- Expansion of mRNA and LNP-based vaccine CDMO services
- Growing outsourcing trend in biopharma
- Rising demand for personalized vaccines
- Emerging markets as vaccine manufacturing hubs
- Key Market Trends
- Growing adoption of viral vector and cell-based vaccine platforms
- ion of modular and single-use manufacturing technologies
- Expansion of fill-finish capabilities
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Vaccine CDMO Market Size & Forecast (2023-2030), By Vaccine Type, USD Million
- Introduction
- mRNA Vaccines
- Viral Vector Vaccines
- Recombinant Protein Vaccines
- Inactivated & Live-Attenuated Vaccines
- Conjugate & Toxoid Vaccines
- DNA Vaccines
- Others
- Global Vaccine CDMO Market Size & Forecast (2023-2030), By Phase, USD Million
- Introduction
- Pre-clinical
- Clinical
- Commercial
- Global Vaccine CDMO Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Biopharmaceutical & Vaccine Developers
- Government & Public Health Agencies
- Others
- Global Vaccine CDMO Market Size & Forecast (2023-2030), By , USD Million
- Introduction
- North America Vaccine CDMO Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Vaccine CDMO Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Market Size & Forecast, By Vaccine Type (USD Million)
- France
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Vaccine CDMO Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Vaccine Type (USD Million)
- Market Size & Forecast, By Phase (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Lonza Group
- Thermo Fisher Scientific
- Catalent, Inc
- Samsung Biologics
- CordenPharma
- WuXi Vaccines
- Recipharm AB
- ICON plc
- FUJIFILM Diosynth Biotechnologies
- Curia Global, Inc.
- Other Prominent Players
Note: *Indicative list
**For listed companies
